Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/15/05 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
13 | |
| 07/28/05 | 1-E | Notification under Regulation E by small business investment companies and business development companies. |
|
1 | |
| 06/03/05 | 1-E | Notification under Regulation E by small business investment companies and business development companies. |
|
1 | |
| 06/02/05 | 8-K | Current report filing |
|
3 | |
| 06/01/05 | 8-K | Current report filing |
|
3 | |
| 06/01/05 | N-54A | Notification of election by business development companies filed on Form N-54A |
|
1 | |
| 05/31/05 | 8-K | Current report filing |
|
9 | |
| 05/10/05 | 10QSB | Optional form for quarterly and transition reports of small business issuers |
|
9 | |
| 03/31/05 | 10KSB | Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405] |
|
18 | |
| 03/23/05 | 8-K | Current report filing |
|
3 |
